Rubius Therapeutics, Inc. Profile Avatar - Palmy Investing

Rubius Therapeutics, Inc.

Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid…

Biotechnology
US, Cambridge [HQ]
Strategy & Leadership

Mergers & Acquisitions Beta

M&A Deals · Breakdown

Rubius Therapeutics, Inc. has no acquisition track records yet.

M&A Deals · History

Rubius Therapeutics, Inc. has no acquisition track records yet.

End of RUBY's Analysis
CIK: 1709401 CUSIP: 78116T103 ISIN: US78116T1034 LEI: - UEI: -
Secondary Listings
RUBY has no secondary listings inside our databases.